Appointed CEO of Bruin Biometrics in 2012, Martin Burns designed and led the successful journey of Bruin Biometrics’ SEM Scanner through the company’s concept-to-commercialization “formulas strategy.” Significant milestones include FDA de novo Marketing Authorization (2018), CE Marking (2013) and in 2020 he negotiated a global distribution arrangement and investment with Arjo. Martins’ background is strategy and operations management consulting to large med tech companies. He earned his MBA from UCLA’s Anderson School of Management, where he is a guest speaker on healthcare strategy and medical device marketing courses, and his BA from the London School of Economics.
Martin Burns: The origins of Bruin Biometrics and the Provizio SEM Scanner
July 9th 2025In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.
Martin Burns of Bruin Biometrics: Leading the way on diagnostic innovation
July 7th 2025In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.